Pathogenic modulators of cellular senescence
Vavilovskii zhurnal genetiki i selektsii · Simoroz EV et al. · Paper published 1 Sep 2026
We haven’t written this paper up. Its abstract belongs to the publisher, so read it at the source.
The paper
Pathogenic modulators of cellular senescence
Simoroz EV, Antonov YV, Muravyov GS et al.
Vavilovskii zhurnal genetiki i selektsii · 1 Sep 2026 · Peer-reviewed
- Relevance
- Core geroscience
- News value
- Routine
- Evidence
- Review
- Status
- Peer-reviewed
More on Cellular senescence
See allDasatinib and quercetin reduce liver fibrosis in a phase-2 MASH trial
The senolytic combination improved liver fibrosis without disease worsening in nearly half of treated participants while lowering cellular senescence markers.
Nature metabolism · Koning M et al.
A distinct p21-driven macrophage senotype accumulates during aging and liver disease
Researchers identified a p53-p21-Cyclin D2 axis that governs senescent macrophages in mice and human liver cirrhosis and can be cleared with senolytics.
bioRxiv · Torres G et al.
DNA methylation proxies of senescence markers track human disease and mortality
The new blood-based tools estimate senescence gene activity to predict incident diseases, all-cause mortality, and clinical treatment responses.
medRxiv · Simpson DJ et al.
Bispecific T cell engager eliminates senescent cells in mice and nonhuman primates
Monitored by serum transaminase levels, low doses of the drug alleviated age-related pathologies without causing the hepatotoxicity seen at higher doses.
Aging cell · Deng J et al.
A deep learning score for cellular senescence predicts human mortality and disease risk
The proteomic biomarker tracked chronic illness risk in the UK Biobank and shifted following an 18-month multimodal exercise intervention.
Aging cell · Zhao S et al.